|
Key: Meeting 
Journal 
Funder 
Showing releases 2876-2900 out of 3325. << < 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | 119 | 120 > >>
Public Release: 12-Jul-2012
Cleveland Clinic researchers receive $5 million grant to discover novel pathways to heart disease
The National Heart, Lung, and Blood Institute has awarded a $4.78 million grant to researchers at Cleveland Clinic's Lerner Research Institute to use metabolomics -- a new approach that focuses on the small-molecule byproducts of metabolism -- for discovery of novel pathways linked to the development of cardiovascular diseases.
NIH/National Heart, Lung, and Blood Institute
Contact: Wyatt DuBois
duboisw@ccf.org
216-445-9946
Cleveland Clinic
Public Release: 12-Jul-2012
$4.7 million study looks at why diabetes makes heart disease worse
Researchers at Washington University School of Medicine in St. Louis have received a $4.7 million grant from the National Heart, Lung, and Blood Institute to investigate heart disease in patients with diabetes.
NIH/National Heart, Lung, and Blood Institute
Contact: Julia Evangelou Strait
straitj@wustl.edu
314-286-0141
Washington University School of Medicine
Public Release: 12-Jul-2012
Louisiana Tech biomedical engineering professor earns recognition, funding for research
Dr. Teresa Murray, assistant professor in biomedical engineering at Louisiana Tech University, has received notice from the National Institute of Health that her proposal titled "Long Term 3D Imaging of Mouse Brain in Vivo to Study Glial Cells and Gliogenesis" was recognized for excellence and will receive funding.
National Institutes of Health
Contact: Dave Guerin
dguerin@latech.edu
318-257-4854
Louisiana Tech University
Public Release: 12-Jul-2012
Sandia seeks commercial partners for revolutionary 'SpinDx' medical diagnostic tool
Researchers at Sandia National Laboratories have developed a lab-on-a-disk platform that they believe will be faster, less expensive and more versatile than similar medical diagnostic tools. Lab officials are seeking industry partners to license and commercialize the SpinDx technology, which can determine a patient's white blood cell count, analyze important protein markers, and process up to 64 assays from a single sample, all in a matter of minutes.
National Institutes of Health
Contact: Mike Janes
mejanes@sandia.gov
925-294-2447
DOE/Sandia National Laboratories
Public Release: 12-Jul-2012
Science
Discovery of chemical that affects biological clock offers new way to treat diabetes
Biologists at UC San Diego have discovered a chemical that offers a completely new and promising direction for the development of drugs to treat metabolic disorders such as Type 2 diabetes -- a major public health concern in the United States due to the current obesity epidemic.
National Institutes of Health
Contact: Kim McDonald
kmcdonald@ucsd.edu
858-534-7572
University of California - San Diego
Public Release: 12-Jul-2012
Current Biology
From aflatoxin to sake
Study maps the genetic changes involved in the domestication of Aspergillus oryzae, one of the fungi used to make sake, soy sauce and miso.
National Institutes of Health, National Science Foundation, Searle Scholars Program
Contact: David Salisbury
david.salisbury@vanderbilt.edu
615-343-6803
Vanderbilt University
Public Release: 12-Jul-2012
Science
Discovery opens door to attacking biofilms that cause chronic infections
Using super-resolution microscopy and continuous fluorescent imaging, UC Berkeley's Veysel Berk has for the first time revealed the structure of bacterial biofilms, which are responsible for the tenacious nature of bacterial diseases such as cholera, chronic sinusitis and lung infections in CF patients. The picture of bacterial apartment buildings provides new targets for the development of drugs that can tear down these structures and expose them to antibiotics.
National Science Foundation, National Institutes of Health
Contact: Robert Sanders
rsanders@berkeley.edu
510-643-6998
University of California - Berkeley
Public Release: 12-Jul-2012
Cell
Dana-Farber study shows newly isolated 'beige fat' cells could help fight obesity
Scientists at Dana-Farber Cancer Institute have isolated a new type of energy-burning fat cell in adult humans which they say may have therapeutic potential for treating obesity.
National Institutes of Health, American Heart Association
Contact: Anne Doerr
anne_doerr@dfci.harvard.edu
617-632-5665
Dana-Farber Cancer Institute
Public Release: 11-Jul-2012
Journal of Virology
UW scientists discover why human body cannot fight HIV infection
University of Washington researchers have made a discovery that sheds light on why the human body is unable to adequately fight off HIV infection. The researchers in the Gale Lab discovered that the viral protein vpu, which is created by HIV during infection, directly interferes with the immune response protein IRF3 to dampen the ability of the immune system to protect against virus infection.
National Institutes of Health
Contact: Bobbi Nodell
bnodell@uw.edu
206-543-8309
University of Washington
Public Release: 11-Jul-2012
Human Molecular Genetics
Mutations in autism susceptibility gene increase risk in boys
Researchers at Emory University School of Medicine have identified five rare mutations in a single gene that appear to increase the chances that a boy will develop an autism spectrum disorder.
Mutations in the AFF2 gene, and other genes like it on the X chromosome, may explain why autism spectrum disorders affect four times as many boys as girls.
National Institutes of Health, NIH/National Institute of Mental Health, Simons Foundation Autism Research Institute
Contact: Quinn Eastman
qeastma@emory.edu
404-727-7829
Emory Health Sciences
Public Release: 11-Jul-2012
True blood: SLU scientist investigates clotting factors
The National Institutes of Health is funding research by Saint Louis University biochemist Alireza Rezaie, Ph.D., on balancing the life-preserving and life-threatening activity of blood clotting.
NIH/National Heart, Lung, and Blood Institute
Contact: Nancy Solomon
solomonn@slu.edu
31-497-778-017
Saint Louis University
Public Release: 11-Jul-2012
PLOS ONE
Using biomarkers to identify and treat schizophrenia
In the current online issue of PLoS ONE, researchers at the University of California, San Diego School of Medicine say they have identified a set of laboratory-based biomarkers that can be useful for understanding brain-based abnormalities in schizophrenia. The measurements, known as endophenotypes, could ultimately be a boon to clinicians who sometimes struggle to recognize and treat the complex and confounding mental disorder.
NIH/National Institute of Mental Health, Department of Veterans Affairs
Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Public Release: 11-Jul-2012
Journal of Clinical Investigation
Scientists first to see trafficking of immune cells in beating heart
Working in mice, surgeons and scientists at Washington University School of Medicine in St. Louis, have captured the first images of a beating heart at a resolution so detailed they can track individual immune cells swarming into the heart muscle, causing the inflammation that is so common after a heart attack or heart surgery.
NIH/National Heart, Lung, and Blood Institute, NIH/National Institute of Allergy and Infectious Diseases
Contact: Caroline Arbanas
arbanasc@wustl.edu
314-286-0109
Washington University School of Medicine
Public Release: 11-Jul-2012
Scripps Research Institute wins $77 million to develop AIDS vaccine center
The Scripps Research Institute has been awarded a grant expected to total more than $77 million from the National Institutes of Health's National Institute of Allergy and Infectious Diseases. The new seven-year project will focus on developing a vaccine against HIV and the disease it causes, AIDS.
NIH/National Institute of Allergy and Infectious Diseases, National Institutes of Health
Contact: Mika Ono
mikaono@scripps.edu
Scripps Research Institute
Public Release: 11-Jul-2012
Health Affairs
Global Budget Payment Model lowers medical spending, improves quality
Researchers find that global budgets for health care, an alternative to the traditional fee-for-service model of reimbursement, can slow the growth of medical spending and improve the quality of care for patients.
Commonwealth Fund, NIH/National Institute on Aging, Charles H. Hood Foundation
Contact: David Cameron
david_cameron@hms.harvard.edu
617-432-0441
Harvard Medical School
Public Release: 11-Jul-2012
Science Translational Medicine
Mayo Clinic finds switch that lets early lung cancer grow unchecked
Cellular change thought to happen only in late-stage cancers to help tumors spread also occurs in early-stage lung cancer as a way to bypass growth controls, say researchers at Mayo Clinic in Florida.
NIH/National Cancer Institute,State of Florida/James & Esther King Biomedical Research Program
Contact: Paul Scotti
scotti.paul@mayo.edu
904-953-2299
Mayo Clinic
Public Release: 11-Jul-2012
Genetics
Decline of immune system with aging may have a genetic cause
By examining fruit flies at two different stages of their lives -- youth and middle age -- a team of US scientists have discovered important insights that explain why our ability to ward off infection declines with age. Their findings that a completely different set of genes ward off infection at middle age than during youth are published in the July 2012 issue of the Genetics Society of America's journal, Genetics.
US Department of Education, NIH/National Institute of General Medical Sciences, Procter and Gamble, National Institutes of Health
Contact: Phyllis Edelman
pedelman@genetics-gsa.org
301-634-7302
Genetics Society of America
Public Release: 11-Jul-2012
PLOS ONE
Anxiety linked to shortened telomeres, accelerated aging
A new study by researchers at Brigham and Women's Hospital shows that a common form of anxiety, known as phobic anxiety, was associated with shorter telomeres in middle-aged and older women. The study suggests that phobic anxiety is a possible risk factor for accelerated aging.
National Institutes of Health
Contact: Marjorie Montemayor-Quellenberg
mmontemayor-quellenberg@partners.org
617-534-2208
Brigham and Women's Hospital
Public Release: 11-Jul-2012
Science Translational Medicine
2 proteins offer a 'clearer' way to treat Huntington's disease
In a paper published in the July 11 online issue of Science Translational Medicine, researchers at the University of California, San Diego School of Medicine have identified two key regulatory proteins critical to clearing away misfolded proteins that accumulate and cause the progressive, deadly neurodegeneration of Huntington's disease.
Hereditary Disease Foundation, CHDI Foundation, National Institutes of Health
Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego
Public Release: 11-Jul-2012
Neurology
Stress reduction therapy prevents MS brain lesions
Stress counseling for patients with multiple sclerosis prevented the development of new brain lesions, a marker of the disease's activity in the brain, reports a new study. Brain lesions in MS often precede flare-ups of symptoms such as loss of vision or use of limbs or pain. This is the first time psychotherapy has been shown to affect development of new brain lesions and the strongest evidence to date that stress is involved in MS.
NIH/National Institute of Child Health & Human Development
Contact: Hilary Hurd Anyaso
h-anyaso@northwestern.edu
847-491-4887
Northwestern University
Public Release: 10-Jul-2012
Proceedings of the National Academy of Sciences
Study reveals new mechanism that might promote cancer's growth and spread in the body
Researchers have discovered a previously unknown mechanism that promotes the growth and spread of cancer. The mechanism involves key immune cells and a new role for small regulatory molecules called microRNA. The findings suggest a new strategy for treating cancer and perhaps diseases of the immune system.
NIH/National Cancer Institute, Kimmel Foundation Fellowship
Contact: Darrell E. Ward
Darrell.Ward@osumc.edu
614-293-3737
Ohio State University Medical Center
Public Release: 10-Jul-2012
Hepatology
Levels of hepatitis C virus higher among African-Americans and males
Epidemiologists have determined that levels of hepatitis C virus (HCV) found among injection drug users (IDUs) were higher in individuals who are male or African-American even after differences in other factors were considered. Results of the study published in the July issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, also showed higher levels of HCV among IDUs who were co-infected with human immunodeficiency virus.
NIH/National Cancer Institute
Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley
Public Release: 10-Jul-2012
Eukaryotic Cell
UMass Amherst researchers unravel secrets of parasites' replication
A group of diseases that kill millions of people each year can't be touched by antibiotics, and some treatment is so harsh the patient can't survive it. They're caused by parasites, and for decades researchers have searched for a "magic bullet" to kill them without harming the patient. Now UMass Amherst microbiologists report the first detailed characterization of the way key proteins in the model parasite Trypanosoma brucei organize to replicate its mitochondrial DNA.
NIH/National Institute of Allergy and Infectious Diseases, National Science Foundation
Contact: Janet Lathrop
jlathrop@admin.umass.edu
413-545-0444
University of Massachusetts at Amherst
Public Release: 10-Jul-2012
Nature Genetics
U-M researchers identify new genetic cause for chronic kidney disease
A new single-gene cause of chronic kidney disease has been discovered that implicates a disease mechanism not previously believed to be related, according to research from the University of Michigan.
National Institutes of Health, Burroughs Wellcome Fund, Doris Duke Charitable Distinguished Clinical Scientist Award, NIH/National Institute of Diabetes and Digestive and Kidney Diseases
Contact: Mary Masson
mfmasson@umich.edu
734-764-2220
University of Michigan Health System
Public Release: 10-Jul-2012
Journal of Youth and Adolescence
Multiracial youths show similar vulnerability to peer pressure as whites
Experts have thought that multiracial adolescents, the fastest growing youth group in the United States, use drugs and engage in violence more than their single-race peers. But in a new study, researchers find that mixed-race adolescents are more similar to their white counterparts than previously believed.
NIH/National Institute on Drug Abuse, NIH/National Institute on Alcohol Abuse and Alcoholism, Australian National Health and Medical Research Council, Australian Research Council
Contact: Molly McElroy
mollywmc@uw.edu
206-543-2580
University of Washington
Showing releases 2876-2900 out of 3325. << < 111 | 112 | 113 | 114 | 115 | 116 | 117 | 118 | 119 | 120 > >>
|
RSS Feed
